· Periodic ReportMajor
Q3 profit from main business KRW 0.9 billion, up 156.6% from a year earlier; sales KRW 12.2 billion
L&K Biomed sold KRW 12.2 billion in Q3 and earned KRW 0.9 billion from its main business, up 156.6% from a year earlier and down 31.9% from the previous quarter.